FDA Approves Voceryq 2026: First Plasmid DNA-Based Immunotherapy for Recurrent Respiratory Papillomatosis
The FDA approval of Voceryq 2026 marks an important advancement in the…
Delhi High Court Relief to AstraZeneca: NPPA Restrained from Coercive Action Over ₹151.19 Crore Symbicort Overcharging Demand
The Delhi High Court has granted interim relief to AstraZeneca Pharma India…
Government Forms Committee to Review Pharmaceutical Marketing Practices in India: Focus on UCPMP 2024
The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has…
India Imported Drugs Shelf Life Rule 2026: New 12-Month Requirement and Gazette Notification
India's Imported Drugs Shelf Life Rule 2026 has been amended by the…
Rajasthan Pharmacist Recruitment 2023: 60 Candidates Protest Over Document Verification
Latest Update: 29 October 2026 | Jaipur, Rajasthan The Rajasthan Pharmacist Recruitment…
CDSCO Alert 2026: Falsified Defitelio Injection Reported in India
Published: October 2026Category: Pharma News | Drug Safety Alert | CDSCO Updates…
GLP-1 Drug Market to Reach $22 Billion by 2035: J.P. Morgan Report
Introduction The GLP-1 drug market by 2035 could reach $22 billion across…
Moderna Loses $24 Billion in Market Value After Cancer Vaccine Data in 2026
Moderna lost approximately $24 billion in market value on October 22, 2026,…
Novo Cuts Norditropin FlexPro Price in India by Up to 35%
Novo has reduced the price of Norditropin FlexPro, a growth hormone medicine,…
Bayer Targets Threefold Consumer Health Growth in India by 2030, Explores GLP-1 Support Products
Bayer India Consumer Health News: Bayer AG aims to triple its consumer…
Eli Lilly Sees Strong Potential in India’s Biotech Ecosystem
Eli Lilly India is placing increasing importance on the country’s biotechnology, research…
Drug Test Reports Public in India: Latest DCC Update
The proposal to make drug test reports public in India through a…
CDSCO Warns Against Indiscriminate Use of NSAIDs and Antibiotics in 2026
New Delhi, September 2026: The CDSCO circular on NSAIDs and antibiotics 2026…
Bharat Biotech Growth Strategy 2026: Vaccines, Gene Therapy, AMR Research & Innovation
Bharat Biotech's growth strategy in 2026 is expanding beyond its established vaccine…
Easier Drug Approval Norms in India 2026: Key Regulatory Changes Explained
India is considering easier drug approval norms in India to streamline selected…
